NEW YORK & MIAMI (December 12, 2022) — The Parkinson’s Foundation today announced the appointment of Mark Keavey as senior vice president and chief financial officer of the nation’s leading community for people with Parkinson’s disease (PD), their loved ones and those working to end the disease. An accomplished financial leader with more than two decades of experience, Keavey will oversee the Foundation’s financial, accounting and IT functions.
“We are delighted to welcome Mark to the Foundation’s leadership team as we work toward fulfilling our vision of a world without Parkinson’s disease,” said John L. Lehr, president and CEO of the Parkinson’s Foundation. “With his substantial experience in the non-profit sector, we are confident in his ability to deliver results and create value in complex financial operations.”
In his previous work, Keavey led initiatives to support organizational growth and change. He has a proven record of leading teams and streamlining business operations to increase efficiency, productivity and performance. Most recently, he served as the vice president of finance for the Cystic Fibrosis Foundation (CFF), where he directed finance department activities. Before CFF, Keavey worked as a manager at a leading accounting firm.
Keavey stated: “I am honored to work with a talented team and organization that is improving care and advancing research to make life better for people living with Parkinson’s disease. I look forward to contributing to the Foundation and the PD community to advance the Foundation’s mission.”
Keavey holds a bachelor’s degree in public accounting from Fordham University’s Gabelli School of Business and is a Certified Public Accountant. He lives in Maryland with his wife, Rebecca, and their two children.
For more information about the Parkinson’s Foundation senior leadership team, visit Parkinson.org/About-Us.
About the Parkinson’s Foundation
The Parkinson’s Foundation makes life better for people with Parkinson’s disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience and passion of our global Parkinson’s community. Since 1957, the Parkinson’s Foundation has invested more than $400 million in Parkinson’s research and clinical care. Connect with us on Parkinson.org, Facebook, Twitter, Instagram or call (800) 4PD-INFO (473-4636).
About Parkinson’s Disease
Affecting an estimated one million Americans and 10 million worldwide, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer’s and is the 14th-leading cause of death in the U.S. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for Parkinson’s and 60,000 new cases are diagnosed each year in the U.S. alone.